M4MM

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

  • Cannabis

Comprehensive Cannabis Pangenome

LOS ANGELES- A collaborative study led by the Salk Institute for Biological Studies has constructed the most comprehensive genetic map of Cannabis sativa to date, analyzing 193 genomes from 144 biological samples. This pangenome reveals ...

California Cannabis Industry Pursues Self-Regulation

LOS ANGELES- In response to ongoing regulatory challenges and concerns about product safety, California's cannabis industry is exploring self-regulation measures to bolster consumer trust and ensure compliance within the legal market. The Environmental Consumer Compliance ...

Texas Expands Medical Cannabis Access

LOS ANGELES- In a significant policy shift, Texas lawmakers have approved House Bill 46, expanding the state's medical cannabis program to include patients with chronic pain and those in hospice or terminal care. The bill ...

Cresco Labs Reschedules Q1 2025 Earnings

LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, ...

Consumers Pay Premium for Fast-Acting Cannabis Edibles

LOS ANGELES- A recent industry analysis reveals that cannabis consumers are increasingly favoring fast-acting edible products, demonstrating a willingness to pay higher prices for quicker onset effects. The 2025 Edibles Premiumization Report, conducted by cannabis ...

Subscribe To Our Newsletter